2 results
Approved WMORecruiting
The aim of this study is to examine the effectiveness of treatment with tDCS in reducing AVH and related symptoms in patients with BPD and AVH
Approved WMORecruiting
The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary…